A Doximity Director Moved 7,500 Shares the Day the Stock Popped 33%. Here's What to Know

On August 7, Doximity director Timothy S. Cabral sold 7,500 shares of the company's Class A Common Stock. The transaction value was calculated at $311,325 based on the weighted average sale price of $39.11 per share. This sale occurred following the adoption of a Rule 10b5-1 trading plan on February 19, which aimed to minimize the role of non-public information in equity liquidation.

Despite the sale, Cabral retains a significant stake - 326,000 direct derivative securities - and maintains long-term interest in the company. As of August 10, the stock had experienced a one-year return of -50%, trading at $25.63. Doximity offers cloud-based digital tools for healthcare practitioners, including networking, patient care management, remote consultations, medical research access, and professional development.

The company's revenue stream comes from a subscription-based model, serving pharmaceutical companies and healthcare organizations that utilize its engagement and communication capabilities.